Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
New drug tested for Tough-to-Treat blood disorder
Disease control CompletedThis study tested an experimental drug called belantamab mafodotin in 35 adults whose AL amyloidosis had returned or stopped responding to previous treatments. AL amyloidosis is a serious condition where abnormal proteins build up and damage organs like the heart and kidneys. The…
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested to control Tough-to-Treat blood cancer
Disease control CompletedThis study tested whether adding a drug called daratumumab to a standard two-drug treatment (pomalidomide and dexamethasone) works better for people with multiple myeloma that has come back or stopped responding to prior treatments. It involved 304 adults whose cancer had progres…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC